minoxidil - Bernstein Medical Center for Hair Restoration - Page 2

Search Results for: minoxidil

About Header Image

Showing results 11 - 20 of 125 for the search term: minoxidil.

, as well as treating acne. The results of clinical trials are pending. Vascular/Angiogenic Related Compounds Regaine/Rogaine (minoxidil) 2% has been used worldwide for over 10 years, and is now over the counter (OTC) in the USA. Most recently, Extra Strength 5% Rogaine has hit the OTC shelves in the USA, with approval in November 1997. Pharmacia-Upjohn has sole rights to being the only manufacturer for the next 3 years for this new version of minoxidil, which is indicated only for men. Despite lack of understanding of the distinct mechanism of action, in women it has been shown to increase the non-vellus hairs when using it for 32 weeks or more2. One potential drawback to minoxidil therapy is that spontaneous reversal to the pretreatment state that can be expected one to three months after cessation of therapy, indicating minoxidil has a direct effect on the hair follicle, sensitizing it and making it dependent on the drug for future growth. The mechanism of action although still unclear, seems to open potassium channels and increases proliferation and differentiation of epithelial cells in the hair shaft2. Serum concentrations after topical application of 2% minoxidil, used twice a day are generally about 5% of…
a, has been a major breakthrough in the medical management of male pattern baldness. Before Propecia, the only medically proven treatment was topical minoxidil (Rogaine) and this medication was only minimally effective and, for many, a nuisance to apply. Propecia, on the other hand, is a once-a-day pill that can significantly alter the progression of genetic balding, particularly if started when the hair loss is still in its early stages. The recent availability of finasteride in a generic, 5mg tablet, has decreased the cost of the drug – for those who don't mind cutting up pills. Avodart (dutasteride), a more potent medication that is related to finasteride, has been approved for the treatment of prostate enlargement, but not hair loss. Because of its affect on the balding process we will discuss this medication as well.
vivo. J Invest Dermatol 1992;98:315-9. Bunker Bunker CB, Dowd PM. Alterations in scalp blood flow after the epicutaneous application of 3% minoxidil and 0.1% hexylnicotinate in alopecia. Br J Dermatol 1987;117:668-9.
ir thickening serums and nutritional supplements are available as well. Products include: Avacor Topical Solution: active ingredient includes 5% Minoxidil which should be applied twice daily to the scalp in the area of hair loss. Avacor Scalp Detoxifying Shampoo: should be used daily prior to the topical solution, and rinsed thoroughly with warm water. Boost! Hair Thickening Serum: used before styling hair. Avacor Therapy Shampoo: should be used at least twice per week. Avacor Nutricap: a dietary supplement which should be taken twice daily. Avacor Loses $50 Million Class Action Lawsuit Six years after initial litigation, Global Vision Products Inc, the manufacturers of Avacor hair regrowth products, has lost its defense of a 50 million dollar, class action lawsuit. Global Vision Products, Inc. declared bankruptcy in January 2008. It was alleged that the marketers of Avacor violated California law by including false and misleading statements and promoting unsubstantiated claims in connection with their advertising and marketing campaigns. Among other items, the company was accused of misrepresenting its product as “herbal based” and “all natural” but contains, among other things the drug Minoxidil, as an active ingredient, the side effects of which were not advertised. References: The National Hair Journal, Vol…

Showing results 11 - 20 of 125 for the search term: minoxidil.




212-826-2400
Scroll to Top
Learn more about hair restoration

Hair loss has a variety of causes. Diagnosis and treatment is best determined by a board-certified dermatologist. We offer both in-person and online photo consults.

Provide your email to learn more.